- Home
- MCW vs TRVI Comparison
MCW vs TRVI Comparison
Compare MCW & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCW
- TRVI
- Stock Information
- Founded
- MCW 1996
- TRVI 2011
- Country
- MCW United States
- TRVI United States
- Employees
- MCW N/A
- TRVI N/A
- Industry
- MCW
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- MCW
- TRVI Health Care
- Exchange
- MCW Nasdaq
- TRVI Nasdaq
- Market Cap
- MCW 1.5B
- TRVI 1.4B
- IPO Year
- MCW 2021
- TRVI 2019
- Fundamental
- Price
- MCW $5.48
- TRVI $10.88
- Analyst Decision
- MCW Buy
- TRVI Strong Buy
- Analyst Count
- MCW 10
- TRVI 9
- Target Price
- MCW $7.65
- TRVI $20.72
- AVG Volume (30 Days)
- MCW 1.9M
- TRVI 1.6M
- Earning Date
- MCW 10-29-2025
- TRVI 11-10-2025
- Dividend Yield
- MCW N/A
- TRVI N/A
- EPS Growth
- MCW 22.84
- TRVI N/A
- EPS
- MCW 0.27
- TRVI N/A
- Revenue
- MCW $1,041,660,000.00
- TRVI N/A
- Revenue This Year
- MCW $6.86
- TRVI N/A
- Revenue Next Year
- MCW $6.87
- TRVI N/A
- P/E Ratio
- MCW $20.55
- TRVI N/A
- Revenue Growth
- MCW 6.98
- TRVI N/A
- 52 Week Low
- MCW $4.61
- TRVI $2.36
- 52 Week High
- MCW $8.60
- TRVI $11.83
- Technical
- Relative Strength Index (RSI)
- MCW 57.99
- TRVI 59.20
- Support Level
- MCW $5.00
- TRVI $10.30
- Resistance Level
- MCW $6.05
- TRVI $11.82
- Average True Range (ATR)
- MCW 0.22
- TRVI 0.56
- MACD
- MCW 0.08
- TRVI -0.04
- Stochastic Oscillator
- MCW 56.98
- TRVI 43.37
About MCW Mister Car Wash Inc.
Mister Car Wash Inc is a car wash brand offering express exterior and interior cleaning services. Express Exterior Locations offers express exterior cleaning services and Interior Cleaning Locations offers both express exterior and interior cleaning services. The company recognizes revenue from activities related to providing car wash services at its car wash locations that are geographically diversified throughout the United States and have similar economic characteristics and nature of services.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.